A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy

Shuang Liu1, Xingyu Chen1, Xiaojin Liu2

  • 1School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China.

Insights

This study developed a novel nanoplatform that depletes glutathione (GSH) and uses near-infrared light to combine photodynamic therapy (PDT) and photothermal therapy (PTT) for enhanced tumor treatment with minimal toxicity.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Intracellular glutathione (GSH) and low reactive oxygen species (ROS) generation hinder phototherapy efficacy in tumors.
  • Developing strategies to overcome tumor antioxidant defenses is crucial for effective cancer treatment.

Purpose of the Study:

  • To construct a dual-modal nanoplatform for enhanced photothermal therapy (PTT) and photodynamic therapy (PDT).
  • To create a nanoplatform that depletes GSH and is triggered by near-infrared (NIR) light for synergistic tumor eradication.

Main Methods:

  • A nanoplatform (Ce6@CDP) was engineered with a copper sulfide (CuS) core and a disulfide bond-containing polymer (DS-ANPA-PEG) encapsulating Ce6.
  • The polymer reacts with intracellular GSH, leading to GSH depletion and increased oxidative stress.
  • CuS core facilitates NIR-triggered PTT, while Ce6 enables PDT, creating a combined therapeutic effect.

Main Results:

  • The nanoplatform effectively depleted GSH and generated ROS, significantly enhancing PDT efficacy.
  • High photothermal conversion efficiency of the CuS core enabled potent PTT under 808 nm laser irradiation.
  • In vitro and in vivo studies confirmed significant tumor growth inhibition with negligible systemic toxicity.

Conclusions:

  • The developed nanoplatform offers a promising strategy for synergistic PDT/PTT by overcoming tumor antioxidant defenses.
  • This GSH-depleting, NIR-triggered system provides a rational design for responsive multimodal nanotherapeutics.
  • The approach shows potential for effective and safe cancer treatment through combined therapeutic modalities.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.6K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.4K
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.5K
BJT Amplifiers01:14

BJT Amplifiers

Bipolar Junction Transistors (BJTs) are pivotal components in amplifier circuits, functioning as voltage-controlled current sources in their active region. This characteristic allows them to efficiently control the collector current through variations in the base-emitter voltage. Essentially, BJTs amplify power due to their ability to take a weak input signal and output a much stronger signal.
In BJT amplifier configurations, particularly in common-emitter setups, the transistor's role...
970
Operational Amplifiers01:17

Operational Amplifiers

The operational amplifier, often referred to as an op-amp, is a multifaceted building block of a circuit. This electronic component functions like a voltage-controlled voltage source and can also be used to create a voltage- or current-controlled current source. The design of an operational amplifier enables it to execute mathematical operations when external components like resistors and capacitors are linked to its terminals. An op-amp has the capacity to sum signals, amplify a signal,...
1.9K
MOSFET Amplifiers01:17

MOSFET Amplifiers

The MOSFET, when operating in its active region, functions as a voltage-controlled current source. In this region, the gate-to-source voltage controls the drain current. This principle underlies the operation of the transconductance MOSFET amplifier. The output current is directed through a load resistor to convert this amplifier into a voltage amplifier. The output voltage is then obtained by subtracting the voltage drop across the load resistance from the supply voltage. This process results...
506